Search

Your search keyword '"Recombinant Proteins analysis"' showing total 61 results

Search Constraints

Start Over You searched for: Descriptor "Recombinant Proteins analysis" Remove constraint Descriptor: "Recombinant Proteins analysis" Journal biotechnology and bioengineering Remove constraint Journal: biotechnology and bioengineering
61 results on '"Recombinant Proteins analysis"'

Search Results

1. Combined gene and environmental engineering offers a synergetic strategy to enhance r-protein production in Chinese hamster ovary cells.

2. A framework for calculating orthogonal selectivities in multimodal systems directly from cell culture fluid.

3. A comparative analysis of recombinant Fab and full-length antibody production in Chinese hamster ovary cells.

4. Simple, rapidly electroassembled thiolated PEG-based sensor interfaces enable rapid interrogation of antibody titer and glycosylation.

5. Development of a rapid polarized total synchronous fluorescence spectroscopy (pTSFS) method for protein quantification in a model bioreactor broth.

6. Autophagy-inducing peptide increases CHO cell monoclonal antibody production in batch and fed-batch cultures.

7. Hydrocyclones as cell retention devices for an N-1 perfusion bioreactor linked to a continuous-flow stirred tank production bioreactor.

8. S-adenosylmethionine and methylthioadenosine boost cellular productivities of antibody forming Chinese hamster ovary cells.

9. A CFD model for predicting protein aggregation in low-pH virial inactivation for mAb production.

10. Random epigenetic modulation of CHO cells by repeated knockdown of DNA methyltransferases increases population diversity and enables sorting of cells with higher production capacities.

11. Overexpression of the mitochondrial pyruvate carrier reduces lactate production and increases recombinant protein productivity in CHO cells.

12. Amino acid supplementation for enhancing recombinant protein production in E. coli.

13. SuptoxD2.0: A second-generation engineered Escherichia coli strain achieving further enhanced levels of recombinant membrane protein production.

14. Statistical modeling of cell-to-cell variability in viral infection during passaging in suspension cell culture: Application in Monte-Carlo simulation.

15. Overexpression of transcription factor Foxa1 and target genes remediate therapeutic protein production bottlenecks in Chinese hamster ovary cells.

16. Influence of cytoskeleton organization on recombinant protein expression by CHO cells.

17. Low concentrations of cadmium chloride promotes protein translation and improve cell line productivity.

18. Fam60A plays a role for production stabilities of recombinant CHO cell lines.

19. Real-time monitoring and control of the load phase of a protein A capture step.

20. Process performance and product quality in an integrated continuous antibody production process.

21. Chemical inhibition of autophagy: Examining its potential to increase the specific productivity of recombinant CHO cell lines.

22. Proteomic differences in recombinant CHO cells producing two similar antibody fragments.

23. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.

24. Temporal characterization of protein production levels from baculovirus vectors coding for GFP and RFP genes under non-conventional promoter control.

25. Blocking endocytotic mechanisms to improve heterologous protein titers in Saccharomyces cerevisiae.

26. Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200-L orbitally-shaken disposable bioreactor.

27. Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures.

28. Fluorescence-based soft sensor for at situ monitoring of Chinese hamster ovary cell cultures.

29. Visualizing infection spread: dual-color fluorescent reporting of virus-host interactions.

30. Cell line profiling to improve monoclonal antibody production.

31. Metabolic profiling of insect cell lines: Unveiling cell line determinants behind system's productivity.

32. High-throughput screening for transglutaminase activities using recombinant fluorescent proteins.

33. Optimized extract preparation methods and reaction conditions for improved yeast cell-free protein synthesis.

34. Long-term adaptation of Saccharomyces cerevisiae to the burden of recombinant insulin production.

35. Bioreactor engineering using disposable technology for enhanced production of hCTLA4Ig in transgenic rice cell cultures.

36. Metabolic analysis of antibody producing CHO cells in fed-batch production.

37. Dynamic transcription factor activity profiling in 2D and 3D cell cultures.

38. Functional heterogeneity and heritability in CHO cell populations.

39. Growth and productivity impacts of periplasmic nuclease expression in an Escherichia coli Fab' fragment production strain.

40. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.

41. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.

42. Regioselective hydroxylation of daidzein using P450 (CYP105D7) from Streptomyces avermitilis MA4680.

43. Protein disulfide isomerase does not control recombinant IgG4 productivity in mammalian cell lines.

44. Triple light chain antibodies: factors that influence its formation in cell culture.

45. Production of recombinant proteins in clonal root cultures using episomal expression vectors.

46. At-line monitoring of bioreactor protein production by Surface Plasmon Resonance.

47. Chemometric analysis of in-line multi-wavelength fluorescence measurements obtained during cultivations with a lipase producing Aspergillus oryzae strain.

48. GlycoVis: visualizing glycan distribution in the protein N-glycosylation pathway in mammalian cells.

49. Integrated non-invasive system for quantifying secreted human therapeutic hIL2.

50. Yeast surface display of a noncovalent MHC class II heterodimer complexed with antigenic peptide.

Catalog

Books, media, physical & digital resources